UVI 3003 是一种高度选择性的类视黄醇 X 受体拮抗剂。在 Cos7 细胞中，它抑制非洲爪蟾蜍和人RXRα的活性，IC50值分别为 0.22 和 0.24 μM。

UVI 3003 is a highly selective antagonist of the retinoid X receptor. UVI 3003 inhibits Xenopus and human RXRα in Cos7 cells (IC50s: 0.22 and 0.24 μM, respectively).

UVI3003 fully activates xPPARγ (EC50: 12.6 μM) and is almost completely inactive on hPPARγ and mPPARγ. UVI 3003 causes a 65.4% difference in EECD34 cell fusion and desmin expression. UVI 3003 (10 μM) does not change the proliferation rate of extraocular muscles (EOM)-derived or LEG-derived EECD34 cells [1][2].

847239-17-2

C28H36O4

436.58

DMSO:100 mg/mL (229.05 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years